727 related articles for article (PubMed ID: 20431074)
1. Activation of protein kinase C isoforms and its impact on diabetic complications.
Geraldes P; King GL
Circ Res; 2010 Apr; 106(8):1319-31. PubMed ID: 20431074
[TBL] [Abstract][Full Text] [Related]
2. The role of protein kinase C activation and the vascular complications of diabetes.
Das Evcimen N; King GL
Pharmacol Res; 2007 Jun; 55(6):498-510. PubMed ID: 17574431
[TBL] [Abstract][Full Text] [Related]
3. High glucose concentrations increase endothelial cell permeability via activation of protein kinase C alpha.
Hempel A; Maasch C; Heintze U; Lindschau C; Dietz R; Luft FC; Haller H
Circ Res; 1997 Sep; 81(3):363-71. PubMed ID: 9285638
[TBL] [Abstract][Full Text] [Related]
4. Protein kinase C beta inhibition: A novel therapeutic strategy for diabetic microangiopathy.
Idris I; Donnelly R
Diab Vasc Dis Res; 2006 Dec; 3(3):172-8. PubMed ID: 17160912
[TBL] [Abstract][Full Text] [Related]
5. The role of protein kinase C activation in the pathogenesis of diabetic vascular complications.
Park JY; Ha SW; King GL
Perit Dial Int; 1999; 19 Suppl 2():S222-7. PubMed ID: 10406523
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase C activation and its role in the development of vascular complications in diabetes mellitus.
Ishii H; Koya D; King GL
J Mol Med (Berl); 1998 Jan; 76(1):21-31. PubMed ID: 9462865
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase C activation: isozyme-specific effects on metabolism and cardiovascular complications in diabetes.
Idris I; Gray S; Donnelly R
Diabetologia; 2001 Jun; 44(6):659-73. PubMed ID: 11440359
[TBL] [Abstract][Full Text] [Related]
8. A novel potential therapy for diabetic nephropathy and vascular complications: protein kinase C beta inhibition.
Tuttle KR; Anderson PW
Am J Kidney Dis; 2003 Sep; 42(3):456-65. PubMed ID: 12955673
[TBL] [Abstract][Full Text] [Related]
9. PKC-B inhibition: a new therapeutic approach for diabetic complications?
Avignon A; Sultan A
Diabetes Metab; 2006 Jun; 32(3):205-13. PubMed ID: 16799396
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase C and the development of diabetic vascular complications.
Way KJ; Katai N; King GL
Diabet Med; 2001 Dec; 18(12):945-59. PubMed ID: 11903393
[TBL] [Abstract][Full Text] [Related]
11. The role of protein kinase C activation in diabetic nephropathy.
Noh H; King GL
Kidney Int Suppl; 2007 Aug; (106):S49-53. PubMed ID: 17653211
[TBL] [Abstract][Full Text] [Related]
12. Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats.
Koya D; Jirousek MR; Lin YW; Ishii H; Kuboki K; King GL
J Clin Invest; 1997 Jul; 100(1):115-26. PubMed ID: 9202063
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of protein kinase C β ameliorates impaired angiogenesis in type I diabetic mice complicating myocardial infarction.
Ikeda A; Matsushita S; Sakakibara Y
Circ J; 2012; 76(4):943-9. PubMed ID: 22313801
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase C activation and the development of diabetic complications.
Koya D; King GL
Diabetes; 1998 Jun; 47(6):859-66. PubMed ID: 9604860
[TBL] [Abstract][Full Text] [Related]
15. Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation.
Inoguchi T; Battan R; Handler E; Sportsman JR; Heath W; King GL
Proc Natl Acad Sci U S A; 1992 Nov; 89(22):11059-63. PubMed ID: 1438315
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase C changes in diabetes: is the concept relevant to neuropathy?
Eichberg J
Int Rev Neurobiol; 2002; 50():61-82. PubMed ID: 12198821
[TBL] [Abstract][Full Text] [Related]
17. The cellular and molecular mechanisms of diabetic complications.
King GL; Brownlee M
Endocrinol Metab Clin North Am; 1996 Jun; 25(2):255-70. PubMed ID: 8799700
[TBL] [Abstract][Full Text] [Related]
18. Induction of endothelin-1 expression by glucose: an effect of protein kinase C activation.
Park JY; Takahara N; Gabriele A; Chou E; Naruse K; Suzuma K; Yamauchi T; Ha SW; Meier M; Rhodes CJ; King GL
Diabetes; 2000 Jul; 49(7):1239-48. PubMed ID: 10909984
[TBL] [Abstract][Full Text] [Related]
19. Can protein kinase C inhibition and vitamin E prevent the development of diabetic vascular complications?
Bursell SE; King GL
Diabetes Res Clin Pract; 1999 Sep; 45(2-3):169-82. PubMed ID: 10588370
[TBL] [Abstract][Full Text] [Related]
20. Ruboxistaurin, a protein kinase C beta inhibitor, as an emerging treatment for diabetes microvascular complications.
Joy SV; Scates AC; Bearelly S; Dar M; Taulien CA; Goebel JA; Cooney MJ
Ann Pharmacother; 2005 Oct; 39(10):1693-9. PubMed ID: 16160002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
